Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

TuHURA Biosciences Stock News

HURANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$2.62

-0.04-1.50%

At close: -

$2.77

0.155.71%

After Hours: 9:01 AM EDT

TuHURA Biosciences (HURA) Forecast

News

Earnings TuHURA Biosciences (HURA) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest TuHURA Biosciences Stock News | NASDAQ:HURA | Benzinga

Get the latest news on TuHURA Biosciences stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on TuHURA Biosciences performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, June 09, 2025

FDA Removes Manufacturing-Related Partial Cli...
Benzinga Newsdesk

Monday, June 02, 2025

TuHURA Biosciences Presents IFx-Hu2.0 Trial-i...
Benzinga Newsdesk

Friday, May 16, 2025

HC Wainwright & Co. Reiterates Buy on TuHURA ...
Benzinga Newsdesk

Thursday, May 15, 2025

TuHURA Biosciences Q1 EPS $(0.15) Misses $(0....
Benzinga Newsdesk

Monday, May 05, 2025

TuHURA Biosciences Initiates Phase 1b/2a Stud...
Benzinga Newsdesk

Monday, April 28, 2025

TuHURA Biosciences And Kineta Present Updated...
Benzinga Newsdesk

Thursday, April 03, 2025

HC Wainwright & Co. Maintains Buy on TuHURA B...
Benzinga Newsdesk

Wednesday, April 02, 2025

TuHURA Biosciences shares are trading higher ...
Benzinga Newsdesk

Tuesday, April 01, 2025

TuHURA Biosciences FY24 EPS ($1.21) Up From (...
Benzinga Newsdesk

Wednesday, March 19, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights

Tuesday, March 18, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
TuHURA Biosciences shares are trading higher ...
Benzinga Newsdesk

Thursday, March 13, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights

Wednesday, March 12, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights

Monday, March 03, 2025

HC Wainwright & Co. Initiates Coverage On TuH...
Benzinga Newsdesk

Wednesday, January 08, 2025

Florida Congresswoman Laurel Lee Has Disclose...
Benzinga Newsdesk

Thursday, December 19, 2024

Rodman & Renshaw Initiates Coverage On TuHURA...
Benzinga Newsdesk

Thursday, December 12, 2024

The Cash Component Of The Aggregate Merger Co...
Benzinga Newsdesk
TuHURA To Acquire Kineta, Adding KVA12123 Che...
Benzinga Newsdesk

Wednesday, November 27, 2024

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights

Monday, November 25, 2024

TuHURA Biosciences Outlines Development Pathw...
Benzinga Newsdesk

Friday, October 25, 2024

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights

Tuesday, October 22, 2024

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights

Monday, October 21, 2024

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved